This study elucidated that β-blocker pretreatment improved the antitumor efficacy of an oncolytic virus, T1012G, by regulating STAT3-PKR dependent antiviral response in gastric cancer cells in response to viral infection and type I IFNs. This evidence concerns the gene EIF2AK2 and gastric cancer.